TRHC - Tabula Rasa HealthCare, Inc.
Chart Events
Price Crosses Moving Average
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 56.97 |
| Open | 57.40 |
| Bid | 53.47 x 1400 |
| Ask | 53.53 x 1800 |
| Day's Range | 51.67 - 57.51 |
| 52 Week Range | 33.04 - 69.72 |
| Volume | 733,447 |
| Avg. Volume | 364,190 |
| Market Cap | 1.23B |
| Beta (5Y Monthly) | 1.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.72 |
| Earnings Date | May 07, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 71.00 |
Fair Value
Related Research
- GlobeNewswire
TRHC’s MedWise Risk Score™ Reduces the Odds of Adverse Drug Events, Keeping Patients Safer
The research article is a 12-month analysis of medical claims data of 1,965 Program of All Inclusive Care for the Elderly (PACE ) participants by TRHC’s Precision Pharmacotherapy Research & Development Institute to determine their MedWise Risk Score™ (MRS). TRHC’s MedWise Risk Score™ helps identify those at highest risk for Adverse Drug Events (ADEs), requiring immediate medication management attention. Adverse Drug Events, if it were a disease, would be the third leading cause of death in the United States.
- Simply Wall St.
Is Now An Opportune Moment To Examine Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), which is in the healthcare services business, and is based in United...
- GlobeNewswire
TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource
Tabula Rasa HealthCare® Corporation (TRHC), a healthcare technology company advancing the field of medication safety, today published on the web the TRHC COVID-19 Treatment and Therapy Digital Resource. Developed by TRHC’s Precision Pharmacotherapy Research & Development Institute, the resource provides a comprehensive analysis and clinical reviews of potential treatments and therapies for COVID-19. “To address this need, our Precision Pharmacotherapy Research & Development Institute completed a systematic review of literature on the latest COVID-19 treatments and therapies and compiled them into a single source, eliminating the need for providers to access multiple sources to understand treatment options.”
- Zacks
HMSY or TRHC: Which Is the Better Value Stock Right Now?
HMSY vs. TRHC: Which Stock Is the Better Value Option?
- Insider Monkey
Was The Smart Money Right About Tabula Rasa HealthCare, Inc. (TRHC)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the coronavirus recession coming, but a lot of hedge funds did. Even we published an article near the end of February and […]
- GlobeNewswire
TRHC and ASCP Sign Letter of Intent to offer MedWise™ to Consultant Pharmacists
MOORESTOWN, N.J., May 11, 2020 -- Tabula Rasa HealthCare®, Inc. (TRHC) (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, today announces.
- Motley Fool
Tabula Rasa HealthCare, Inc. Common Stock (TRHC) Q1 2020 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Tabula Rasa HealthCare, Inc. first-quarter 2020 earnings conference call. Certain statements made during this call will be forward-looking statements within the meaning of that law.
- Zacks
Tabula Rasa Healthcare (TRHC) Q1 Earnings Match Estimates
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 0.00% and 1.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Tabula Rasa HealthCare Reports First Quarter 2020 Results
MOORESTOWN, N.J., May 07, 2020 -- Tabula Rasa HealthCare®, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today reported.
- GlobeNewswire
TRHC and Speed Script Expand Partnership for Clinical Documentation
MOORESTOWN, N.J., May 04, 2020 -- Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today.
- Zacks
Tabula Rasa Healthcare (TRHC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tabula Rasa Healthcare (TRHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?
CPSI vs. TRHC: Which Stock Is the Better Value Option?
- Zacks
Why Tabula Rasa Healthcare (TRHC) is Poised to Beat Earnings Estimates Again
Tabula Rasa Healthcare (TRHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- GlobeNewswire
TRHC Launches First Large Simulation Study to Assess Adverse Drug Events with proposed COVID-19 Treatments
Tabula Rasa HealthCare Corporation® (TRHC), a healthcare technology company advancing the field of medication safety, announced today its running of a clinical study assessing the risk of adverse drug events (ADEs) associated with drugs repurposed for the treatment of COVID-19 in older adults on multiple medications. “This study showcases the depth and breadth of our clinical research capabilities,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “The results from the study will provide the framework for additional clinical trials that will continue to demonstrate the value of our risk stratification algorithms and processes.”
- GlobeNewswire
Tabula Rasa HealthCare to Release First Quarter 2020 Operating Results May 7, 2020
Tabula Rasa HealthCare, Inc. (TRHC), will release its first quarter 2020 operating results Thursday, May 7, 2020, after market close, on the investor relations section of TRHC’s website at ir.trhc.com. A conference call hosted by THRC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; and TRHC Chief Financial Officer, Brian W. Adams will follow at 5:00 p.m. EDT. The conference call will be broadcast live in listen-only mode on the investor relations section of TRHC’s website (ir.trhc.com).
- GlobeNewswire
Tabula Rasa HealthCare and Strategic Solutions Network Partner on a Free COVID-19 Medication Safety Webinar
Tabula Rasa HealthCare Corporation® (TRHC), a healthcare technology company advancing the field of medication safety, and Strategic Solutions Network, a privately-held business-to-business conference company, will present a free webinar entitled Important Medication Safety Considerations for COVID-19 Treatment on Thursday, May 7, 2020 at 1 p.m. EDT. The webinar will discuss the importance of understanding the risks associated with COVID-19 treatment risks, particularly with vulnerable individuals who have several chronic diseases and take multiple medications.
- Zacks
Zacks.com featured highlights include: Ionis Pharmaceuticals, Aphria, Tabula Rasa Healthcare, InterDigital and Huron Consulting Group
Zacks.com featured highlights include: Ionis Pharmaceuticals, Aphria, Tabula Rasa Healthcare, InterDigital and Huron Consulting Group
- GlobeNewswire
Tabula Rasa HealthCare’s DoseMeRx™ Integrates with The Sanford Guide
MOORESTOWN, N.J., April 21, 2020 -- Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and.
- Zacks
Grab 5 Top Stocks With Strong Earnings Beat Prospects
Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.
- GlobeNewswire
Tabula Rasa HealthCare® and CQuentia® Expand Partnership with COVID-19 Test Kit Distribution Agreement
Tabula Rasa HealthCare®, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced an expanded laboratory services agreement with CQuentia, a comprehensive analytics platform and molecular laboratory for personalized medicine. The agreement provides TRHC with access to COVID-19 (SARS-CoV-2 RNA) testing kits for distribution to Programs of All-Inclusive Care for the Elderly (PACE) through TRHC’s CareKinesis Pharmacy. Through its relationship with CQuentia, TRHC also expects to have future access to new point-of-care, rapid testing technologies as well as to serological testing to determine whether a patient has COVID-19 antibodies.
- Simply Wall St.
Does Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Salary Reflect Performance?
Calvin Knowlton became the CEO of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) in 2014. This report will, first, examine...
- American City Business Journals
Tabula Rasa partnership to provide COVID-19 test kits to thousands of pharmacies
Tabula Rasa HealthCare Corp. said Monday its has entered into a partnership with HealthQuest Esoterics to support the preparation and delivery of thousands of coronavirus testing kits. Under the partnership, the testing kits will be available for more than 3,000 community pharmacies that are part of Tabula Rasa's "PrescribeWellness" nationwide network. The kits will detect SARS-CoV-2, the virus that causes COVID-19.
- GlobeNewswire
TRHC Provides COVID-19 Testing Opportunities to Community Pharmacies Across the United States
Tabula Rasa HealthCare Corporation® (TRHC), a healthcare technology company advancing the field of medication safety, announced today a partnership with Irvine-based HealthQuest Esoterics, Inc. to support the preparation and delivery of thousands of testing kits for the detection of SARS-CoV-2, the virus that causes Coronavirus Disease 2019 (COVID-19). The testing kits will be available for TRHC’s PrescribeWellness nationwide network of community pharmacies. TRHC’s COVID-19 operationalized response preceded the U.S. Department of Health & Human Services (HHS) recent declaration granting licensed pharmacists authority under the Public Readiness and Emergency Preparedness Act (PREP Act).
- GlobeNewswire
EPIC Pharmacy Network Renews Contract with TRHC’s PrescribeWellness®
EPN will use PrescribeWellness Solutions to Improve Patient Care Across the U.S. EPN is one of the largest, independently owned pharmacy services administration organizations and managed care networks for independent pharmacies in the nation.
- GlobeNewswire
VigiLanz® Announces Precision Dosing Powered by Tabula Rasa HealthCare’s DoseMeRx™
Tabula Rasa HealthCare, Inc® (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, has partnered with VigiLanz®, the leading provider in clinical surveillance, to integrate with DoseMeRx™, TRHC’s precision dosing solution. The integration of DoseMeRx within VigiLanz’s award winning software platform will provide hospital customers with instant access to personalized dosing for vancomycin and other antimicrobials, optimizing pharmacy workflow and improving patient safety.
